Bicocca Open Archive

Logo unimib boa
MEZZADRI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.170
NA - Nord America 967
EU - Europa 724
SA - Sud America 209
Continente sconosciuto - Info sul continente non disponibili 63
AF - Africa 28
OC - Oceania 1
Totale 3.162
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 922
IT - Italia 422
SG - Singapore 363
VN - Vietnam 283
CN - Cina 161
BR - Brasile 149
HK - Hong Kong 124
RU - Federazione Russa 60
IN - India 48
BD - Bangladesh 45
FR - Francia 40
DE - Germania 37
GB - Regno Unito 33
KR - Corea 28
NL - Olanda 26
SE - Svezia 26
AR - Argentina 25
CA - Canada 24
ID - Indonesia 24
FI - Finlandia 20
AE - Emirati Arabi Uniti 14
MX - Messico 13
ES - Italia 11
TR - Turchia 11
AT - Austria 10
IQ - Iraq 10
EC - Ecuador 9
JP - Giappone 9
PL - Polonia 9
ZA - Sudafrica 8
CL - Cile 7
CO - Colombia 7
PH - Filippine 7
MA - Marocco 6
CH - Svizzera 5
IE - Irlanda 5
NP - Nepal 5
OM - Oman 5
PK - Pakistan 5
PY - Paraguay 5
JO - Giordania 4
SA - Arabia Saudita 4
TW - Taiwan 4
UA - Ucraina 4
UY - Uruguay 4
AL - Albania 3
CR - Costa Rica 3
EG - Egitto 3
GR - Grecia 3
LT - Lituania 3
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
MY - Malesia 2
PE - Perù 2
PT - Portogallo 2
TN - Tunisia 2
TZ - Tanzania 2
BE - Belgio 1
BH - Bahrain 1
BO - Bolivia 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
ET - Etiopia 1
FJ - Figi 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
IR - Iran 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
MU - Mauritius 1
NG - Nigeria 1
NO - Norvegia 1
PA - Panama 1
PS - Palestinian Territory 1
QA - Qatar 1
SN - Senegal 1
TT - Trinidad e Tobago 1
UG - Uganda 1
UZ - Uzbekistan 1
VC - Saint Vincent e Grenadine 1
Totale 3.099
Salva come PNG Salva come JPEG
Città #
Singapore 164
Dallas 157
San Jose 149
Ashburn 113
Hong Kong 112
Milan 95
Ho Chi Minh City 79
Hanoi 69
Hefei 57
Los Angeles 50
Rome 36
New York 30
Seoul 27
Beijing 25
Buffalo 21
Chicago 20
Munich 19
Council Bluffs 16
Da Nang 16
Jakarta 14
Lauterbourg 14
Santa Clara 14
São Paulo 13
Hải Dương 11
Boardman 10
Frankfurt am Main 10
Kolkata 10
Moscow 10
Al Ain City 9
Atlanta 9
Biên Hòa 9
Haiphong 9
Palermo 9
Tokyo 9
Turku 9
Chennai 8
Orem 8
Amsterdam 7
Hyderabad 7
Lappeenranta 7
Montreal 7
Newark 7
Padova 7
Seregno 7
Turin 7
Vienna 7
Warsaw 7
Denver 6
Johannesburg 6
Kent 6
London 6
Naples 6
Paris 6
Perugia 6
Philadelphia 6
Phoenix 6
The Dalles 6
Bollate 5
Brooklyn 5
Bến Tre 5
Catania 5
Florence 5
Houston 5
Madrid 5
Milwaukee 5
Poplar 5
Princeton 5
Quito 5
Stockholm 5
Thái Bình 5
Baghdad 4
Bari 4
Bengaluru 4
Bologna 4
Ha Long 4
Montevideo 4
Monza 4
Quận Bình Thạnh 4
Rio de Janeiro 4
San Francisco 4
Santiago 4
Toronto 4
Trento 4
Asunción 3
Athens 3
Bogotá 3
Brescia 3
Campinas 3
Curitiba 3
Dublin 3
Fes 3
Gradara 3
Kathmandu 3
Lecce 3
Medellín 3
Mumbai 3
Muscat 3
Nibionno 3
Nottingham 3
Novate Milanese 3
Totale 1.738
Salva come PNG Salva come JPEG
Nome #
Hepatitis B core antibody positivity is not associated with risk of transaminase elevation following switch to dual antiretroviral therapy 321
Infezione disseminata da Mycobacterium avium complex con batteriemia persistente in un paziente AIDS-presenter [Disseminated Mycobacterium avium complex infection with persistent bacteremia in an AIDS-presenter patient] 306
Ceftazidime-avibactam plus aztreonam versus cefiderocol in the treatment of infections caused by Metallo-β lactamase-Producing Microorganisms: real-word data from the Italian cohort SUSANA 276
Comparison of meropenem-vaborbactam with ceftazidime-avibactam in the treatment of carbapenem-resistant Enterobacterales infections 239
Anti-spike antibody level is associated with the risk of clinical progression among subjects hospitalized with COVID-19 pneumonia: results from a retrospective cohort study 224
Symptomatic neurocognitive impairmentassociated to CNS viral escape in an HIV-1 infected patient: a case report. 217
Long-term durability of dolutegravir + darunavir/cobicistat dual regimen in highly antiretroviral-experienced people living with HIV (DoDaco study) 215
Clinical use of dalbavancin in the Italian SUSANA cohort (SUrveillance of SAfety and outcome of New Antibiotics) 203
Long-term durability of dolutegravir plus darunavir/cobicistat dual regimen in highly antiretroviral-experienced people with HIV (DoDaco study) 177
Comparison of meropenem-vaborbactam vs ceftazidime-avibactam in the treatment of KPC producing Klebsiella pneumoniae infections 175
Late-Onset Combined Immunodeficiency presenting with Progressive Multifocal Leukoencephalopathy and associated Immune Reconstitution Inflammatory Syndrome 170
Mpox Virus in the Pharynx of Men Having Sex with Men: A Case Series 155
Aspergillus Endocarditis: A Rare but Serious Complication During Treatment With Ibrutinib 135
Impact of cefiderocol therapy on patient survival across different multidrugresistant Gram-negative bacilli infections. 123
HBV status modulates transaminase decrease after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in people with HIV 75
Potential for replacing protease inhibitor with doravirine in cART-experienced subjects successfully treated with darunavir-cobicistat plus dolutegravir dual regimen 73
Clinical characteristics and treatment patterns of carbapenem-resistant bloodstream infections in a multi-centre Italian cohort. 24
Reasons for discontinuation of single-tablet regimen rilpivirine/emtricitabine/tenofovir alafenamide (RPV/FTC/TAF) in the era of 2nd-generation INSTIs 23
Imported case of avian influenza A(H9N2) virus infection in a patient with miliary tuberculosis, Italy, March 2026 19
When Faster Diagnosis Is Not Enough: Bringing Diagnostic Stewardship into Antimicrobial Stewardship 12
Totale 3.162
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.941
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.941
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202326 0 0 0 0 0 0 0 0 5 5 6 10
2023/2024144 8 7 22 5 7 7 8 7 14 38 11 10
2024/2025775 14 40 27 8 29 31 41 17 34 90 123 321
2025/20262.074 180 139 269 230 206 80 300 74 105 203 117 171
2026/2027143 142 1 0 0 0 0 0 0 0 0 0 0
Totale 3.162